{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:19:30Z","timestamp":1794385170393,"version":"4.9.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/01.aog.0000450758.95422.c8","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T07:41:10Z","timestamp":1400744470000},"page":"1398-1402","source":"Crossref","is-referenced-by-count":102,"title":["Committee Opinion No. 602"],"prefix":"10.1097","volume":"123","member":"276","reference":[{"key":"R2-51-20210126","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":". Effectiveness of long-acting reversible contraception.","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-51-20210126","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006.","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"key":"R8-51-20210126","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s001980170033","article-title":"Pregnancy and lactation confer reversible bone loss in humans.","volume":"12","author":"Karlsson","year":"2001","journal-title":"Osteoporos Int"},{"key":"R9-51-20210126","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1001\/jama.1993.03500240074029","article-title":". Changes in bone density with lactation.","volume":"269","author":"Sowers","year":"1993","journal-title":"JAMA"},{"key":"R10-51-20210126","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ajcn\/63.1.72","article-title":"Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements.","volume":"63","author":"Ulrich","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"R11-51-20210126","first-page":"569","article-title":"Spinal bone density in women using depot medroxyprogesterone contraception.","volume":"92","author":"Cundy","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R12-51-20210126","first-page":"576","article-title":"A prospective, controlled study of the effects of hormonal contraception on bone mineral density.","volume":"98","author":"Berenson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R13-51-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-7824(02)00308-6","article-title":"Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.","volume":"65","author":"Wanichsetakul","year":"2002","journal-title":"Contraception"},{"key":"R14-51-20210126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001648-200209000-00015","article-title":"Injectable hormone contraception and bone density: results from a prospective study published erratum appears in Epidemiology 2002;13:749.","volume":"13","author":"Scholes","year":"2002","journal-title":"Epidemiology"},{"key":"R15-51-20210126","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","article-title":"Effects of hormonal contraception on bone mineral density after 24 months of use.","volume":"103","author":"Berenson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R16-51-20210126","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.fertnstert.2006.05.024","article-title":"Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.","volume":"86","author":"Clark","year":"2006","journal-title":"Fertil Steril"},{"key":"R17-51-20210126","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.fertnstert.2004.04.064","article-title":"Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.","volume":"82","author":"Clark","year":"2004","journal-title":"Fertil Steril"},{"key":"R18-51-20210126","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review.","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"R19-51-20210126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","article-title":"Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.","volume":"74","author":"Kaunitz","year":"2006","journal-title":"Contraception"},{"key":"R20-51-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bmj.308.6923.247","article-title":"Recovery of bone density in women who stop using medroxyprogesterone acetate.","volume":"308","author":"Cundy","year":"1994","journal-title":"BMJ"},{"key":"R21-51-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R22-51-20210126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.contraception.2007.11.002","article-title":". Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.","volume":"77","author":"Johnson","year":"2008","journal-title":"Contraception"},{"key":"R23-51-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","article-title":". Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.","volume":"81","author":"Harel","year":"2010","journal-title":"Contraception"},{"key":"R24-51-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"R25-51-20210126","first-page":"736","article-title":"Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health.","volume":"95","author":"Petitti","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R26-51-20210126","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2265.1998.00582.x","article-title":"The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.","volume":"49","author":"Orr-Walker","year":"1998","journal-title":"Clin Endocrinol"},{"key":"R27-51-20210126","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2010.11.007","article-title":"Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.","volume":"84","author":"Viola","year":"2011","journal-title":"Contraception"},{"key":"R28-51-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s001980170155","article-title":"The impact of lifestyle factors on stress fractures in female Army recruits.","volume":"12","author":"Lappe","year":"2001","journal-title":"Osteoporos Int"},{"key":"R29-51-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.whi.2006.09.003","article-title":"Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities.","volume":"16","author":"Watson","year":"2006","journal-title":"Womens Health Issues"},{"key":"R30-51-20210126","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1210\/jc.2010-0032","article-title":"Use of depot medroxyprogesterone acetate and fracture risk.","volume":"95","author":"Meier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-51-20210126","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/AOG.0b013e318283d1a1","article-title":". Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.","volume":"121","author":"Lanza","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R32-51-20210126","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","article-title":"The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women.","volume":"78","author":"Vestergaard","year":"2008","journal-title":"Contraception"},{"key":"R35-51-20210126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/jc.2002-020874","article-title":". A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.","volume":"88","author":"Cundy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-51-20210126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajog.2004.07.041","article-title":". Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.","volume":"192","author":"Cromer","year":"2005","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.AOG.0000450758.95422.c8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T09:33:11Z","timestamp":1636536791000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201406000-00051"}},"subtitle":["Depot Medroxyprogesterone Acetate and Bone Effects"],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aog.0000450758.95422.c8","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}